JYNARQUE

Otsuka Patient Assistance Foundation Patient Guide: How to Get JYNARQUE at Low or No Cost

JYNARQUE (tolvaptan) is a prescription medication used to slow the progression of autosomal dominant polycystic kidney disease (ADPKD) in adults at risk of rapidly declining kidney function. The Otsuka Patient Assistance Foundation offers this important treatment at no cost to eligible uninsured or underinsured patients who meet income and other requirements.

About JYNARQUE and Why Access Matters

JYNARQUE is an oral tablet taken twice daily that works by blocking vasopressin receptors in the kidneys, reducing cyst growth and kidney enlargement in ADPKD—a genetic condition causing fluid-filled kidney cysts that can lead to kidney failure. Early treatment can preserve kidney function longer, delaying the need for dialysis or transplant. However, its high list price (often over $500,000 annually) makes it inaccessible without assistance. The Otsuka Patient Assistance Foundation bridges this gap by providing free medication to those who qualify, ensuring patients don't skip doses due to cost.

Who Qualifies?

This program targets U.S. residents who are uninsured or underinsured (e.g., insurance denies coverage or prior authorization fails) and have limited income. You must have a valid prescription from a U.S. healthcare provider. Importantly:

• No U.S. citizenship required, but proof of U.S. residency is mandatory.
• Income limits apply based on household gross income; exact Federal Poverty Level (FPL) percentages aren't publicly specified but require documentation showing financial need.
• Patients with Medicare, Medicaid, or certain commercial insurance may qualify if underinsured (e.g., coverage denied).
• Healthcare provider involvement is key—they complete much of the form and submit it.

Income Eligibility Breakdown

Specific income thresholds aren't fixed publicly and vary; applications are reviewed case-by-case with proof of household income for all contributing members. Provide one document per person, such as:

No income? Enter zero and explain. Incomplete income proof delays approval. Expect financial documentation review to confirm eligibility.

Insurance Requirements

• Uninsured patients: Fully eligible if other criteria met.
• Underinsured: Submit denial proof, like:
  • Explanation of Benefits (EOB)
  • Insurance statement
  • Prior authorization denial letter
• Medicare/Medicaid: May qualify if program denies coverage; include denial docs.
• Active commercial insurance: Often ineligible unless coverage is rejected.

Step-by-Step Application Process

Work with your doctor—they handle most steps via the OPAF Care Connect portal (www.otsukapatientassistance.com) for fastest processing.

1. Discuss with your healthcare provider (HCP): Confirm JYNARQUE prescription. They access forms at Patient Forms section or Apply for Your Patients portal.
2. Patient completes sections:
   • Sign patient authorization (page 2).
   • Fill personal info (name, address, DOB, contacts; include caregiver if applicable).
   • Detail insurance (yes/no; add denial docs if underinsured).
   • List household income and attach proofs.
   • Provide proof of residency (e.g., utility bill, driver's license, rental agreement, or HCP attestation).
3. Gather required documents:
   • Prescription (required in NY, NJ, IA; recommended everywhere).
   • Proof of income (all household).
   • Proof of residency.
   • Insurance denial (if applicable).
4. Submit (HCP or patient):
   • Fastest: Online portal (48 hours eligibility check).
   • Fax: 1-844-727-6274.
   • Mail: Otsuka Patient Assistance Foundation, PO Box varies (e.g., Chesterfield, MO 63006—confirm current on site).
   • Phone help: (888) 591-9812 or 1-855-727-6274 (Mon-Fri, 8AM-8PM ET).
5. Watch for notifications: HCP and patient contacted on status.

Tip: Complete apps process quicker; missing docs cause delays.

Timeline and Delivery

• Online submission: Eligibility in up to 48 hours; full process ~2-3 business days.
• Paper (fax/mail): Up to 5 business days after receipt.
• Approved? Medication shipped free to your home (no cost). You'll get mailed notice.
• Reauthorization required: Ongoing assistance isn't automatic—reauth needed periodically (HCP resubmits updated info).

Alternatives if Denied or Ineligible

• Appeal: Contact OPAF if more info helps (they'll reach out via HCP).
• Manufacturer savings cards: Check Otsuka copay programs for insured patients (separate from OPAF).
• Other assistance:
  • PAN Foundation or HealthWell for kidney disease grants.
  • State ADPKD programs or NeedyMeds.org.
  • Generic tolvaptan (if available; none currently).
  • Clinical trials via ClinicalTrials.gov.
• No biosimilars for JYNARQUE.

Important Disclaimer

This guide is for informational purposes based on available program details as of latest data. Eligibility isn't guaranteed—OPAF reviews each case. Rules can change; visit www.otsukapatientassistance.com or call (888) 591-9812 for updates. Not medical advice—consult your doctor. OPAF is independent; Otsuka doesn't control decisions. Report side effects: Otsuka at 1-800-438-9927 or FDA at 1-800-FDA-1088.

(Word count: 942)